Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated to version v2.11.2, with new additions from late September and early October, while the previous version v2.11.0 and several older entries have been removed.SummaryDifference0.5%
- Check22 days agoChange DetectedThe website has added a plan to make IPD and related data dictionaries available, along with sharing large scale genomic sequencing data with dbGaP subscribers, while also noting the resolution of delays in displaying study record information.SummaryDifference1%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.7%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check87 days agoChange DetectedThe study has been updated to version v2.10.0, with the previous version v2.9.7 now removed.SummaryDifference0.3%
Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.